If you are not happy with the results below please do another search
The US FDA has approved Bracco Diagnostics Gadopiclenol injection, a new, highly stable macrocyclic gadolinium-based contrast agent (GBCA), which shows the highest relaxivity compared to all the other GBCAs available in the United States. Bracco Diagnostics is the United States subsidiary of Bracco Imaging, a world leader in diagnostic imaging.
GE Healthcare has introduced Omni Legend, the first system on its all-new, all-digital PET/CT platform. This cutting-edge system features a brand-new category of digital BGO (dBGO) detector material with a small crystal size that delivers more than two times the sensitivity of prior digital scanners, enabling faster total scan times and impressive small lesion detectability. […]
Biotronik presented data from the full-cohort 2-year BIOSOLVE-IV study in a poster session at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2022. Principal investigator Prof. Dr Johan Bennett presented the recent findings and highlighted the low TLF rate and the low scaffold thrombosis rate of Magmaris Resorbable Magnesium Scaffold (RMS).
Greiner Bio-One’s new Urine Cup with Integrated Transfer Device enables the collection and transport of urine samples safely to the requested destination. Thanks to the integrated transfer device, sample transfer from the cup to an evacuated tube is simple, fast and hygienic.
Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year in underserved communities by 2030, together with Philips and RAD-AID International, have announced a multi-year cross-continental partnership to promote access to diagnostic ultrasound services in ten countries.
UK first aid wholesalers, Aero Healthcare, have reported that the AED (Automated External Defibrillator) market has continued to experience strong year on year growth in the United Kingdom, with the company recording a 47% increase in AED sales since 2020 alongside a global market growth of 35%. The 47% increase equates to more than 10,000 […]
A Welsh MedTech company is taking next steps towards launching its unique technology, after securing a partnership with a leading medical devices company.
Inceptua Early Access and Sentynl Therapeutics, a U.S.-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases have entered into a partnership to make Sentynl’s Nulibry available via an Early Access Program for eligible patients with molyb- denum cofactor deficiency (MoCD) Type A.
Catalysed by the pandemic, the overall virtual clinical trials market has grown rapidly and is now valued at US$7.8 billion with a projected growth of 14% per annum [1]. Cambridge Cognition is an active player in the central nervous system (CNS) market, supplying digital solutions to assess brain health. Now, in a major strategic move […]
Becton, Dickinson and Company (BD), a leading global medical technology company, and Biocorp, a medical device and delivery systems manufacturer based in France, have signed an agreement with the aim of using connected technology to track adherence for self-administered drug therapies, like biologics.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.